Global Nucleic Acid Testing Market Poised for Growth: Key Insights and Forecast to 2030

Dublin, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The "Nucleic Acid Testing Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to's offering.

The latest research publication on the nucleic acid testing market highlights the sector’s promising future prospects, with the market expected to reach an estimated $6.7 billion by 2030. Showcasing an impressive compound annual growth rate (CAGR) of 11.2% from 2024 to 2030, the analysis decomposes the nucleic acid testing industry into detailed segments and offers an in-depth look into future market dynamics.

Robust Expansion Projected Amidst Rising Diagnostic Demands

The study draws attention to several critical trends bolstering the nucleic acid testing market, including the escalating need for precise and rapid diagnostic tests, a growing requirement for nucleic acid test kits in blood banks and transfusion centers, and the rising incidence of cancer, genetic disorders, and infectious diseases.

Nucleic Acid Testing Segmentation and Competitive Landscape

The comprehensive report segments the market into product types, which cover technologies like Polymerase Chain Reaction and Whole Genome Sequencing. It further classifies the market by indications such as infectious disease and cancer. In terms of end-use, the analysis covers settings ranging from hospitals & clinics to academic & research organizations. A substantial part of the publication is devoted to profiling leading companies in the nucleic acid testing arena. These firms are at the forefront of the industry due to their commitment to expanding manufacturing capabilities, advancing research and development, and reducing production costs, all to serve an escalating customer demand for innovative products.

Regional Insights and Market Drivers

Infectious disease is identified as the most significant segment driving the market due to the widespread use of nucleic acid testing kits for identifying genotypes and subtypes. North America is anticipated to lead growth owing to a high prevalence of infectious diseases and robust government support in the region.

A selection of companies mentioned in this report includes

  • F. Hoffmann-La Roche
  • Becton and Dickinson
  • Danaher
  • Abbott Laboratories
  • Illumina
  • Siemens Healthineers
  • bioMerieux

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Contact Data